Related Experiment Video
Updated: Jan 14, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Juxtaposed with another zinc finger protein 1: A factor involved in vitamin K-induced apoptosis
Naoya Yasuda1, Yuri Haneishi1, Yuri Tanioka1
1Faculty of International Agriculture and Food Studies, Department of International Food and Agricultural Science, Tokyo University of Agriculture, 1-1-1, Sakuragaoka, Setagaya-ku, Tokyo, 156-0054, Japan.
Abstract:
Vitamin K2 (VK2) demonstrates potent anticancer properties, primarily through the induction of apoptosis across diverse cell types. Previous work identified its epoxide metabolite (VK2-O) as the effector that covalently modifies the pro-apoptotic protein Bcl-2 antagonist killer 1 (Bak1), a mechanism termed VK2ation, which triggers the mitochondrial apoptotic pathway. However, the precise regulatory mechanism of this reaction remained entirely undefined. Here, we identify juxtaposed with another zinc finger protein 1 (JAZF1) as a crucial upstream regulator. We confirm a VK2-O dependent interaction between JAZF1 and Bak1 in live cells and unequivocally demonstrate that JAZF1 is essential for both the VK2ation of Bak1 and the subsequent VK2-induced apoptosis. These findings establish JAZF1 as an indispensable component of this newly characterized post-translational modification, substantially clarifying the molecular mechanism of VK2 function and advancing the development of VK2-based therapeutics.
Insights
Vitamin K2 (VK2) induces cancer cell death by modifying the Bak1 protein. This study identifies JAZF1 as essential for this VK2ation process and VK2-induced apoptosis, clarifying VK2
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Vitamin K2 (VK2) exhibits anticancer properties by inducing apoptosis.
- The epoxide metabolite of VK2 (VK2-O) covalently modifies Bak1 via VK2ation, initiating apoptosis.
- The upstream regulation of VK2ation and VK2-induced apoptosis was previously unknown.
Purpose of the Study:
- To identify the upstream regulator of VK2ation and VK2-induced apoptosis.
- To elucidate the molecular mechanism of Vitamin K2's anticancer effects.
Main Methods:
- Live-cell imaging to confirm JAZF1 and Bak1 interaction.
- Functional assays to assess JAZF1's role in VK2ation and apoptosis.
Main Results:
- Juxtaposed with another zinc finger protein 1 (JAZF1) was identified as a key regulator.
- A VK2-O dependent interaction between JAZF1 and Bak1 was confirmed in live cells.
- JAZF1 is essential for Bak1 VK2ation and subsequent VK2-induced apoptosis.
Conclusions:
- JAZF1 is an indispensable component of the VK2ation post-translational modification.
- This study clarifies the molecular mechanism of VK2's anticancer activity.
- Findings advance the development of Vitamin K2-based cancer therapeutics.
More Related Videos
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
08:20Analysis of Apoptosis in Zebrafish Embryos by Whole-mount Immunofluorescence to Detect Activated Caspase 3
Published on: December 20, 2013
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades